Marker Therapeutics (MRKR) Other Gross PP&E Adjustments (2018 - 2023)
Marker Therapeutics (MRKR) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$525000.0 as the latest value for Q2 2023.
- On a quarterly basis, Other Gross PP&E Adjustments fell 106.69% to -$525000.0 in Q2 2023 year-over-year; TTM through Mar 2024 was -$525000.0, a 104.42% decrease, with the full-year FY2022 number at $11.6 million, up 6829.45% from a year prior.
- Other Gross PP&E Adjustments was -$525000.0 for Q2 2023 at Marker Therapeutics, down from $11.9 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $11.9 million in Q1 2023 to a low of -$14.4 million in Q4 2020.
- A 5-year average of $654249.6 and a median of -$244568.0 in 2019 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: plummeted 54752.59% in 2020, then surged 6829.45% in 2022.
- Marker Therapeutics' Other Gross PP&E Adjustments stood at -$26174.0 in 2019, then tumbled by 54752.59% to -$14.4 million in 2020, then skyrocketed by 101.17% to $167390.0 in 2021, then soared by 6829.45% to $11.6 million in 2022, then plummeted by 104.53% to -$525000.0 in 2023.
- Per Business Quant, the three most recent readings for MRKR's Other Gross PP&E Adjustments are -$525000.0 (Q2 2023), $11.9 million (Q1 2023), and $11.6 million (Q4 2022).